"We're seeing a surprising number of patients who were vaccinated and are still affected by the virus," he said. "We think the vaccine is not a perfect match with strains that are coming through the area."
Alger said she noticed improvement after the first dose on the new drug.
"Last night after my first dosing, my cough had improved, as well as the irritation in my chest," she said.
After three doses, Derek Peterson dramatically recovered. He was really sick. In fact, initially, he could hardly make it to north Foothill Clinic for his first treatment.
"I mean, I curled up in a ball in a fetal position, just miserable," he said. "I was like that the entire first day."
It appears to work against a variety of influenzas, including bird flu and the so-called para-influenza bugs. Since the compound is a derivative from natural human flora, the mist produces no allergic reactions.
If the third-stage clinical trials prove out, the FDA could approve the compound within the year under its "fast-track" program. The Utah study group is looking for more volunteers to test the new drug. For more information go to www.jlewisresearch.com or call 801-480-9392.
Contributing: Jennifer Stagg and Carole Mikita
- LDS Church reaffirms stance on immigration
- Husband says he didn't know about wife's...
- Graphic video shows 7 shots fired without...
- U., Ute Tribe reach agreement on continued...
- Doug Robinson: The first kiss and the long...
- Utah cyclist dies Sunday at the age of 23
- 7 dead babies found in Pleasant Grove garage;...
- Study: Fathers as likely as mothers to kill...
- LDS Church reaffirms stance on immigration 97
- 7 dead babies found in Pleasant Grove... 74
- Utah attorney general encourages... 57
- U., Ute Tribe reach agreement on... 37
- Doug Robinson: The first kiss and the... 24
- Mom accused of killing 6 newborns held... 24
- Moab's dilemma: Can recreation coexist... 23
- Southern Utah left wanting for water 11